Malignant astrocytomas have well identified molecular characteristics and a basic pattern of common genetic alterations, which include PTEN, TP53, IDH1/2 and p16 mutations, and EGFR, CDK4 and MDM2 amplification [1,6]. The gene discussed is EGFR; the disease is astrocytoma (excluding glioblastoma).